Seck Katharina, Saupe Steffen, Kiechle Marion, Harbeck Nadia
Frauenklinik und Poliklinik der Technischen Universität München, Germany.
Breast Care (Basel). 2009 Nov;4(5):328-331. doi: 10.1159/000236066. Epub 2009 Oct 22.
Many patients with intravenous chemotherapy have an intravenous port system because of high tissue toxicity of most chemotherapeutic agents in the case of paravasation. With more port systems implanted, the rate of complications is increasing. Apart from catheter thrombosis, we primarily know of fracture of the port catheter.
We describe 3 patients of our chemotherapeutic clinic who experienced complications of the intravenous port system implanted in the vena brachialis. All of them showed fracture and loss of the port catheter, followed in some cases by symptoms such as cardiac problems.
We have to discuss the use of intravenous port systems. Besides their comfortable use, intravenous port systems have to be handled with care and it has to be considered in every case if there really is the need for an implantation.
由于大多数化疗药物在发生外渗时对组织毒性高,许多接受静脉化疗的患者会使用静脉输液港系统。随着植入的输液港系统增多,并发症发生率也在上升。除了导管血栓形成外,我们主要还了解到输液港导管断裂的情况。
我们描述了3例在我们化疗门诊接受了肱静脉植入静脉输液港系统的患者所经历的并发症。他们均出现了输液港导管断裂和丢失的情况,部分病例随后出现了心脏问题等症状。
我们必须讨论静脉输液港系统的使用问题。除了使用方便外,静脉输液港系统必须小心处理,并且在每种情况下都必须考虑是否真的有植入的必要。